How will cancer look in the year 2025? More than fifty UK cancer care specialists – physicians, scientists, health managers, economists, health service watchers – together with cancer charities and patients spent two days together [more]
Transatlantic collaboration shows results
In the world of oncology drugs, Roche is one of the giants. Here, Chief Executive Franz Humer talks about the research and business strategies behind his company’s success, and about novel therapies in the pipeline [more]
At the tender age of 29, Dr Pinedo found himself in charge of a group of cancer patients who were being left to die, and he set out to find a way to treat them. [more]
Europe’s patient advocates gather for the first time
The European Breast Cancer Conference set up by researchers, clinicians and advocates who wanted to co-ordinate their work and widen the fight against cancer to include the public and politicians. This year it took place [more]
Dispatches from the European front
A new vaccine obtained from the patient’s own tumour tissue may offer the first effective adjuvant treatment for renal-cell carcinoma following surgery. The findings of the phase III clinical trial are being hailed as a [more]
Hewlett Packard does its bit to bridge the digital divide
What do patients have a right to expect from their oncologists? Cancer World asked glioma patient Ivan Noble for his views, after he issued a public Plea to the Medics in his widely read Tumour [more]
It seemed like a gamble when the European Institute of Oncology opened in Milan ten years ago. But this centre of excellence reversed the brain drain and set some of the highest standards for patient-centred [more]